NCT04367935View on ClinicalTrials.gov

Effect of Pentoxifylline on Endothelial Dysfunction in Patients With Acute Coronary Syndrome

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

January 1, 2021

Primary Completion Date

April 25, 2022

Study Completion Date

April 25, 2022

Conditions
Acute Coronary Syndrome
Interventions
DRUG

Pentoxifylline

Pentoxifylline tablets 400mg three times daily for 2 months

Trial Locations (1)

11588

Ain Shams University Hospitals, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT04367935 - Effect of Pentoxifylline on Endothelial Dysfunction in Patients With Acute Coronary Syndrome | Biotech Hunter | Biotech Hunter